(Q34475547)

2 August 2017

title

Costs of delivering human papillomavirus vaccination to schoolgirls in Mwanza Region, Tanzania (English)

1 reference

2 August 2017

0 references

Wilm Quentin

1

0 references

Richard J. Hayes

Richard Hayes

9

0 references

Saidi H Kapiga

Saidi Kapiga

8

0 references

John Changalucha

3

John Changalucha

1 reference

2 August 2017

Fern Terris-Prestholt

2

Fern Terris-Prestholt

1 reference

2 August 2017

5

W John Edmunds

1 reference

2 August 2017

10

Deborah Watson-Jones

1 reference

2 August 2017

Selephina Soteli

4

1 reference

2 August 2017

Raymond Hutubessy

6

1 reference

2 August 2017

David A Ross

7

1 reference

2 August 2017

language of work or name

English

0 references

publication date

13 November 2012

1 reference

2 August 2017

1 reference

2 August 2017

volume

10

1 reference

2 August 2017

page(s)

137

1 reference

A case study using the United Republic of Tanzania: costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing Tool

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520755

A qualitative study of HPV vaccine acceptability among health workers, teachers, parents, female pupils, and religious leaders in northwest Tanzania

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520755

Human papillomavirus vaccination in Tanzanian schoolgirls: cluster-randomized trial comparing 2 vaccine-delivery strategies

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520755

Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520755

Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520755

Comparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520755

Long term protection against cervical infection with the human papillomavirus: review of currently available vaccines

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520755

An overview on the implementation of HPV vaccination in Europe

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520755

Projected health benefits and costs of pneumococcal and rotavirus vaccination in Uganda

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520755

The cost-effectiveness of rotavirus vaccination in Malawi

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520755

Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520755

Health systems and immunization financing for human papillomavirus vaccine introduction in low-resource settings

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520755

Influence of timing of sexual debut and first marriage on sexual behaviour in later life: findings from four survey rounds in the Kisesa cohort in northern Tanzania

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520755

Incremental system costs of introducing combined DTwP-hepatitis B-Hib vaccine into national immunization services in Ethiopia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520755

Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520755

Chapter 2: The burden of HPV-related cancers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520755

Global cancer statistics, 2002

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520755

A comparison of four approaches for measuring clinician time use.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520755

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520755

Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3520755

HPV vaccines and the prevention of cervical cancer

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1741-7015-10-137

Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: modeling of sustained antibody responses

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1741-7015-10-137

Human papillomavirus vaccines. WHO position paper

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23148516

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine: up to 8.4 years of follow-up

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23148516

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1741-7015-10-137

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference

2 August 2017

1 reference